These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 61174)

  • 1. Rapid quantitation of interferon with chronically oncornavirus-producing cells.
    Aboud M; Weiss O; Salzberg S
    Infect Immun; 1976 Jun; 13(6):1626-32. PubMed ID: 61174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of interferon on the synthesis of virus particles in oncornavirus carrier cell lines. III. Survey of effects on A-, B- and C-type oncornaviruses.
    Billiau A; Edy VG; De Clercq E; Heremans H; De Somer P
    Int J Cancer; 1975 Jun; 15(6):947-53. PubMed ID: 50292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of murine leukemia virus production in chronically infected AKR cells: a novel effect of interferon.
    Friedman RM; Ramseur JM
    Proc Natl Acad Sci U S A; 1974 Sep; 71(9):3542-4. PubMed ID: 4139716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assay of human interferon in Vero cells by several methods.
    Ferreira PC; Peixoto ML; Silva MA; Golgher RR
    J Clin Microbiol; 1979 Apr; 9(4):471-5. PubMed ID: 222803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of exogenous interferon on the course of latent oncornavirus infection of J-96 cells].
    Solov'ev VD; Kitsak VIa; Bektemirov TA; Bocharov AF; Moĭsiadi SA
    Vopr Virusol; 1977; (2):196-202. PubMed ID: 898896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of interferon on the synthesis of virus particles in oncornavirus carrier cell lines. IV. Relevance to the potential application of interferon in natural infectious diseases.
    Billiau A; Heremans H; Allen PT; De Somer P
    J Infect Dis; 1976 Jun; 133 Suppl():A51-5. PubMed ID: 180210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon antagonists induced by Newcastle disease virus (NDV).
    Galliot B; Moreau MC; Renard N; Chany C
    Proc Soc Exp Biol Med; 1973 Jan; 142(1):266-70. PubMed ID: 4345719
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential sensitivity of Rauscher murine leukaemia virus (MuLV-R) to interferons in two interferon-responsive cell lines.
    Allen PT; Schellekens H; Van Griensven LJ; Billiau A
    J Gen Virol; 1976 Jun; 31(3):429-35. PubMed ID: 58965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple and efficient microassay method for titration of interferon.
    Ishitsuka H; Nomura Y; Takano K
    Microbiol Immunol; 1977 Oct; 21(10):583-91. PubMed ID: 201822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting the sensitivity of different viruses to interferon.
    Hallum JV; Thacore HR; Youngner JS
    J Virol; 1970 Aug; 6(2):156-62. PubMed ID: 4322869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Production of virus-induced and mitogen-induced interferons by canine cells].
    Georgadze II; Orlova TG; Topuriia NV; Agladze MG; Togoshvili RG
    Vopr Virusol; 1990; 35(6):486-8. PubMed ID: 1707197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid, quantitative, semiautomated assay for virus-induced and immune human interferons.
    Green JA; Yeh TJ; Overall JC
    J Clin Microbiol; 1980 Sep; 12(3):433-8. PubMed ID: 6163794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of the sensitivity of vesicular stomatitis virus to interferons.
    Ito Y; Montagnier L
    Infect Immun; 1977 Oct; 18(1):23-7. PubMed ID: 198374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation and breakdown of RNA-deficient intracellular virus particles in interferon-treated NIH 3T3 cells chronically producing Moloney murine leukemia virus.
    Aboud M; Hassan Y
    J Virol; 1983 Feb; 45(2):489-95. PubMed ID: 6187933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of interferon on murine leukaemia virus infection. IV. Formation of non-infectious virus in chronically infected cells.
    Pitha PM; Wivel NA; Fernie BF; Harper HP
    J Gen Virol; 1979 Mar; 42(3):467-80. PubMed ID: 85689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of human interferon on viral production in a cell line chronically infected by a type D retrovirus (Mason-Pfizer virus)].
    Rhodes-Feuillette A; Cavalieri F; Canivet M; Périès J
    C R Seances Acad Sci D; 1979 May; 288(16):1239-41. PubMed ID: 88278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of oncornavirus RNA-directed DNA polymerase, the RNA template, and the intracellular products formed early during infection and cell transformation.
    Green M; Grandgenett D; Gerard G; Rho HM; Loni MC; Robins M; Salzberg S; Shanmugam G; Bhaduri S; Vecchio G
    Cold Spring Harb Symp Quant Biol; 1975; 39 Pt 2():975-85. PubMed ID: 50902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA-dependent DNA polymerase activity in preparations of a mutant of Newcastle disease virus arising from persistently infected L cells.
    Furman PA; Hallum JV
    J Virol; 1973 Sep; 12(3):548-55. PubMed ID: 4127031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of interferon synthesis to abortive replication of Newcastle disease virus in L cells.
    Youngner JS; Scott AW
    J Virol; 1968 Jan; 2(1):81-2. PubMed ID: 5742030
    [No Abstract]   [Full Text] [Related]  

  • 20. Survey of interferon production and sensitivity human cell lines.
    Moehring JM; Stinebring WR; Merchant DJ
    Appl Microbiol; 1971 Jul; 22(1):102-5. PubMed ID: 4329429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.